Variant report

Variant	esv10744
Chromosome Location	chr11:67435244-67438519
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:70)
CpG islands
(count:61)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:70 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr11:67437130-67437820	HepG2	liver:	n/a	n/a
2	CTCF	chr11:67437936-67437982	Spleen_OC	spleen:	n/a	n/a
3	CTCF	chr11:67436293-67436345	GM20000	blood:	n/a	n/a
4	CTCF	chr11:67435631-67435654	Spleen_OC	spleen:	n/a	n/a
5	CTCF	chr11:67436380-67436530	GM12873	blood:	n/a	n/a
6	CTCF	chr11:67437522-67437624	GM19239	blood:	n/a	n/a
7	EBF1	chr11:67435380-67435725	GM12878	blood:	n/a	chr11:67435534-67435545
8	EBF1	chr11:67437194-67437501	GM12878	blood:	n/a	n/a
9	EBF1	chr11:67435364-67435858	GM12878	blood:	n/a	chr11:67435534-67435545
10	EBF1	chr11:67435275-67435868	GM12878	blood:	n/a	chr11:67435352-67435361 chr11:67435534-67435545
11	EBF1	chr11:67437596-67437833	GM12878	blood:	n/a	n/a
12	EGR1	chr11:67435403-67435564	GM12878	blood:	n/a	chr11:67435473-67435487 chr11:67435477-67435487 chr11:67435477-67435486 chr11:67435471-67435486 chr11:67435477-67435487
13	FOSL2	chr11:67437193-67437498	HepG2	liver:	n/a	n/a
14	GABPA	chr11:67437149-67437794	Hela-S3	cervix:	n/a	n/a
15	GABPA	chr11:67437161-67437484	HepG2	liver:	n/a	n/a
16	HEY1	chr11:67437175-67437491	K562	blood:	n/a	n/a
17	IRF4	chr11:67437040-67437912	GM12878	blood:	n/a	n/a
18	IRF4	chr11:67437083-67437950	GM12878	blood:	n/a	n/a
19	IRF4	chr11:67436072-67436447	GM12878	blood:	n/a	n/a
20	MAX	chr11:67437282-67437336	HepG2	liver:	n/a	n/a
21	MYC	chr11:67437375-67437376	MCF-7	breast:	n/a	n/a
22	MYC	chr11:67437351-67437372	MCF-7	breast:	n/a	n/a
23	MYC	chr11:67437351-67437374	MCF-7	breast:	n/a	n/a
24	MYC	chr11:67437402-67437412	MCF-7	breast:	n/a	n/a
25	MYC	chr11:67437244-67437387	H1-hESC	embryonic stem cell:	n/a	n/a
26	MYC	chr11:67437375-67437438	MCF-7	breast:	n/a	n/a
27	NFIC	chr11:67435215-67435770	ECC-1	luminal epithelium:	n/a	n/a
28	NR3C1	chr11:67437065-67437828	A549	lung:	n/a	n/a
29	NR3C1	chr11:67437103-67437679	A549	lung:	n/a	n/a
30	PAX5	chr11:67437127-67437294	GM12878	blood:	n/a	n/a
31	PAX5	chr11:67437154-67437424	GM12878	blood:	n/a	n/a
32	PAX5	chr11:67437539-67437706	GM12878	blood:	n/a	n/a
33	PAX5	chr11:67437566-67437823	GM12878	blood:	n/a	n/a
34	PAX5	chr11:67435257-67435755	GM12878	blood:	n/a	n/a
35	PAX5	chr11:67437103-67437850	GM12878	blood:	n/a	n/a
36	PAX5	chr11:67435388-67435722	GM12878	blood:	n/a	n/a
37	PAX5	chr11:67435355-67435697	GM12878	blood:	n/a	n/a
38	PBX3	chr11:67437206-67437467	GM12878	blood:	n/a	n/a
39	PBX3	chr11:67437618-67437774	GM12878	blood:	n/a	n/a
40	PBX3	chr11:67437536-67437785	GM12878	blood:	n/a	n/a
41	PBX3	chr11:67437164-67437499	GM12878	blood:	n/a	n/a
42	POLR2A	chr11:67437030-67437073	HepG2	liver:	n/a	n/a
43	POLR2A	chr11:67438173-67438178	MCF-7	breast:	n/a	n/a
44	POLR2A	chr11:67437329-67437372	MCF-7	breast:	n/a	n/a
45	POLR2A	chr11:67438181-67438184	MCF-7	breast:	n/a	n/a
46	POLR2A	chr11:67437265-67437457	MCF-7	breast:	n/a	n/a
47	POLR2A	chr11:67437088-67437373	HepG2	liver:	n/a	n/a
48	POLR2A	chr11:67437855-67437882	MCF-7	breast:	n/a	n/a
49	POLR2A	chr11:67437845-67437849	MCF-7	breast:	n/a	n/a
50	POLR2A	chr11:67435434-67435533	ProgFib	skin:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:67435577-67435627	HRPEpiC	eye:	n/a
2	chr11:67435577-67435627	GM12891	blood:	n/a
3	chr11:67435577-67435627	PFSK-1	brain:	n/a
4	chr11:67435577-67435627	A549	lung:	n/a
5	chr11:67435577-67435627	AG04449	skin:	fetal
6	chr11:67435577-67435627	HCM	heart:	n/a
7	chr11:67435577-67435627	GM12892	blood:	n/a
8	chr11:67435577-67435627	T-47D	breast:	n/a
9	chr11:67435577-67435627	HCF	heart:	n/a
10	chr11:67435577-67435627	ovcar-3	ovarian:	n/a
11	chr11:67435577-67435627	IMR90	lung:	fetal
12	chr11:67435577-67435627	NT2-D1	testis:	n/a
13	chr11:67435577-67435627	HNPCEpiC	eye:	n/a
14	chr11:67435577-67435627	HRE	kidney:	n/a
15	chr11:67435577-67435627	MCF-7	breast:	n/a
16	chr11:67435577-67435627	SK-N-SH	brain:	n/a
17	chr11:67435577-67435627	AG09319	gingival:	n/a
18	chr11:67435577-67435627	K562	blood:	n/a
19	chr11:67435577-67435627	ProgFib	skin:	n/a
20	chr11:67435577-67435627	SKMC	muscle:	n/a
21	chr11:67435577-67435627	RPTEC	kidney:	n/a
22	chr11:67435577-67435627	SK-N-MC	brain:	n/a
23	chr11:67435577-67435627	LNCaP	prostate:	n/a
24	chr11:67435577-67435627	Hela-S3	cervix:	n/a
25	chr11:67435577-67435627	SK-N-SH_RA	brain:	n/a
26	chr11:67435577-67435627	AoSMC	blood vessel:	n/a
27	chr11:67435577-67435627	SAEC	small airway:	n/a
28	chr11:67435577-67435627	HCT-116	colon:	n/a
29	chr11:67435577-67435627	HEEpiC	esophagus:	n/a
30	chr11:67435577-67435627	NHBE	bronchial:	n/a
31	chr11:67435577-67435627	PrEC	prostate:	n/a
32	chr11:67435577-67435627	MCF10A-Er-Src	breast:	n/a
33	chr11:67435577-67435627	HMEC	breast:	n/a
34	chr11:67435577-67435627	Hepatocyte	liver:	n/a
35	chr11:67435577-67435627	HPAEpiC	pulmonary alveolar:	n/a
36	chr11:67435577-67435627	BJ	skin:	n/a
37	chr11:67435577-67435627	GM06990	blood:	n/a
38	chr11:67435577-67435627	HAEpiC	amniotic membrane:	n/a
39	chr11:67435577-67435627	BE2_C	brain:	n/a
40	chr11:67435577-67435627	Jurkat	blood:	n/a
41	chr11:67435577-67435627	GM19239	blood:	n/a
42	chr11:67435577-67435627	HUVEC	blood vessel:	n/a
43	chr11:67435577-67435627	NHDF-neo	bronchial:	n/a
44	chr11:67435577-67435627	AG04450	lung:	fetal
45	chr11:67435577-67435627	HRCEpiC	kidney:	n/a
46	chr11:67435577-67435627	CMK	blood:	n/a
47	chr11:67435577-67435627	U87	brain:	n/a
48	chr11:67435577-67435627	HEK293	kidney:	embryo
49	chr11:67435577-67435627	AG10803	skin:	n/a
50	chr11:67435577-67435627	PANC-1	pancreas:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:67438405..67443993-chr11:67447780..67452157,7	MCF-7	breast:
2	chr11:67435965..67437552-chr11:67440638..67442252,2	MCF-7	breast:
3	chr11:67380317..67383233-chr11:67433739..67435714,2	MCF-7	breast:
4	chr11:67397077..67399431-chr11:67436542..67439337,2	K562	blood:
5	chr11:67396980..67398688-chr11:67437438..67439851,2	MCF-7	breast:
6	chr11:67437911..67440480-chr11:67441652..67443889,5	MCF-7	breast:
7	chr11:67434481..67439568-chr11:67439660..67443258,9	MCF-7	breast:

No data

Variant related genes	Relation type
ALDH3B2	TF binding region
ALDH3B2	CpG island
ENSG00000231793	chromatin interactions
ENSG00000239559	chromatin interactions
ENSG00000167799	chromatin interactions
ENSG00000132746	chromatin interactions

Extended variants
information (count: 227 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:227 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs376336036	chr11:67435246-67435247	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs376834519	chr11:67435255-67435256	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs570305616	chr11:67435256-67435257	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs3928535	chr11:67435351-67435352	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs370335691	chr11:67435359-67435360	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs78445943	chr11:67435364-67435365	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs574505014	chr11:67435370-67435371	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs542176495	chr11:67435438-67435439	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs553857247	chr11:67435456-67435457	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs538473600	chr11:67435485-67435486	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs572536601	chr11:67435489-67435490	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs545970264	chr11:67435502-67435503	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs141851174	chr11:67435530-67435531	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs536712030	chr11:67435539-67435540	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs544139189	chr11:67435548-67435549	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs190579012	chr11:67435550-67435551	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs4646821	chr11:67435569-67435570	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs12288316	chr11:67435583-67435584	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs2514019	chr11:67435608-67435609	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs186338719	chr11:67435618-67435619	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs527423220	chr11:67435654-67435655	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs551854118	chr11:67435673-67435674	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs570319961	chr11:67435678-67435679	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs78203380	chr11:67435694-67435695	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs550420003	chr11:67435707-67435708	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs376070345	chr11:67435729-67435730	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs537612991	chr11:67435757-67435758	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs77149086	chr11:67435810-67435811	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs191189623	chr11:67435845-67435846	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs116654357	chr11:67435902-67435903	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs554178454	chr11:67435916-67435917	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs572345793	chr11:67435927-67435928	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs12295420	chr11:67435950-67435951	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs182404662	chr11:67435954-67435955	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs576725428	chr11:67435955-67435956	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs187777414	chr11:67435968-67435969	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs34589365	chr11:67435976-67435977	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs574312621	chr11:67435984-67435985	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs370041080	chr11:67436017-67436018	Weak transcription Flanking Active TSS Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs557742467	chr11:67436037-67436038	Weak transcription Flanking Active TSS Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs560144107	chr11:67436050-67436051	Weak transcription Flanking Active TSS Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs527247354	chr11:67436077-67436078	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs201969802	chr11:67436098-67436099	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs114216273	chr11:67436146-67436147	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs112472355	chr11:67436173-67436174	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs531282637	chr11:67436200-67436201	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs538748596	chr11:67436207-67436208	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs113459909	chr11:67436226-67436227	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs549598021	chr11:67436265-67436266	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs111169978	chr11:67436279-67436280	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Metanephric adenoma	20802469	CNVD
Chordoma	21602918	CNVD
Melanoma	18172304	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Breast cancer	21806811	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21364760	CNVD
Acute myeloid leukemia	21251322	CNVD
Lung cancer	19153074	CNVD
lymphocytic leukemia	21291569	CNVD
Colorectal cancer	22860045	CNVD
Hirschsprung''s Disease	21712996	CNVD
Schizophrenia	21399695	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
small cell lung cancer	20016488	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	20967226	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:52 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:67430600-67440800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr11:67431200-67437800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr11:67433200-67435400	Enhancers	Fetal Thymus	thymus
4	chr11:67433400-67436600	Enhancers	Primary B cells from peripheral blood	blood
5	chr11:67433600-67435400	Enhancers	Primary B cells from cord blood	blood
6	chr11:67434000-67442400	Weak transcription	Fetal Intestine Small	intestine
7	chr11:67434200-67435800	Enhancers	GM12878-XiMat	blood
8	chr11:67434200-67436000	Enhancers	Spleen	Spleen
9	chr11:67434400-67435800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
10	chr11:67434400-67436600	Weak transcription	Esophagus	oesophagus
11	chr11:67434400-67438600	Enhancers	Placenta	Placenta
12	chr11:67434600-67436200	Enhancers	Thymus	Thymus
13	chr11:67434600-67437400	Flanking Active TSS	Dnd41	blood
14	chr11:67435000-67435600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr11:67435200-67435400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
16	chr11:67435200-67435600	Enhancers	Primary hematopoietic stem cells	blood
17	chr11:67435200-67435800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr11:67435400-67435600	Flanking Active TSS	Primary B cells from cord blood	blood
19	chr11:67435400-67435800	Flanking Active TSS	Fetal Thymus	thymus
20	chr11:67435600-67436000	Enhancers	Primary B cells from cord blood	blood
21	chr11:67435600-67438200	Weak transcription	Primary hematopoietic stem cells	blood
22	chr11:67435600-67438400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr11:67435800-67436400	Enhancers	Fetal Thymus	thymus
24	chr11:67436000-67436200	Weak transcription	Spleen	Spleen
25	chr11:67436000-67436600	Flanking Active TSS	Primary B cells from cord blood	blood
26	chr11:67436000-67437000	Active TSS	Fetal Kidney	kidney
27	chr11:67436200-67437800	Weak transcription	Thymus	Thymus
28	chr11:67436400-67437200	Active TSS	Fetal Thymus	thymus
29	chr11:67436600-67436800	Enhancers	Spleen	Spleen
30	chr11:67436600-67437000	Active TSS	Primary B cells from cord blood	blood
31	chr11:67436600-67437200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
32	chr11:67436600-67437200	Strong transcription	Esophagus	oesophagus
33	chr11:67437000-67437200	Enhancers	Gastric	stomach
34	chr11:67437000-67438400	Weak transcription	Primary B cells from cord blood	blood
35	chr11:67437200-67437800	Weak transcription	Esophagus	oesophagus
36	chr11:67437200-67437800	Weak transcription	Fetal Thymus	thymus
37	chr11:67437200-67441600	Weak transcription	Gastric	stomach
38	chr11:67437400-67437800	Enhancers	Dnd41	blood
39	chr11:67437800-67438000	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr11:67437800-67438000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr11:67437800-67438000	Enhancers	Fetal Thymus	thymus
42	chr11:67437800-67438000	Flanking Active TSS	Dnd41	blood
43	chr11:67437800-67438400	Enhancers	Thymus	Thymus
44	chr11:67437800-67439000	Genic enhancers	Esophagus	oesophagus
45	chr11:67438000-67438400	Weak transcription	Fetal Thymus	thymus
46	chr11:67438000-67438600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr11:67438000-67439000	Enhancers	Dnd41	blood
48	chr11:67438000-67442000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
49	chr11:67438200-67438600	Enhancers	Primary hematopoietic stem cells	blood
50	chr11:67438400-67438800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links